Predictions
Formycon AG
Start price
Target price
Perf. (%)
€60.40
18.01.21
18.01.21
€80.00
18.01.22
18.01.22
-9.93%
04.10.21
04.10.21
Could be worthwhile Investment >10% per year
Aurinia Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€11.99
15.01.21
15.01.21
-
4.50%
05.02.21
05.02.21
Risky Investment
DBV Technologies S.A.
Start price
Target price
Perf. (%)
€8.16
15.01.21
15.01.21
-
15.01.22
15.01.22
-63.58%
16.01.22
16.01.22
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Aphria Inc.
Start price
Target price
Perf. (%)
€9.43
14.01.21
14.01.21
€28.00
72.92%
12.03.21
12.03.21
Could be worthwhile Investment >10% per year
Very Future proof/growth oriented business model
Revenue growth >5% per year expected
Johnson & Johnson
Start price
Target price
Perf. (%)
€132.40
14.01.21
14.01.21
€144.00
14.01.22
14.01.22
10.89%
15.01.22
15.01.22
Canopy Growth Corp
Start price
Target price
Perf. (%)
€26.70
14.01.21
14.01.21
€34.00
14.01.22
14.01.22
-22.75%
28.06.21
28.06.21
Boiron S.A.
Start price
Target price
Perf. (%)
€37.60
13.01.21
13.01.21
€41.00
13.01.22
13.01.22
2.53%
13.04.21
13.04.21
Could be worthwhile Investment >10% per year
First Wave BioPharma Inc.
Start price
Target price
Perf. (%)
€1,583.9
13.01.21
13.01.21
€2,097.9
13.01.22
13.01.22
-83.55%
14.01.22
14.01.22
Intercept Pharmaceuticals
Start price
Target price
Perf. (%)
€23.48
13.01.21
13.01.21
-
25.98%
07.02.21
07.02.21
Risky Investment
Esperion Therapeutis.Inc.
Start price
Target price
Perf. (%)
€22.20
13.01.21
13.01.21
-
26.35%
07.02.21
07.02.21
Could be very worthwhile Investment >20% year
Intercept Pharmaceuticals
Start price
Target price
Perf. (%)
€24.01
13.01.21
13.01.21
-
13.01.22
13.01.22
-28.20%
01.07.21
01.07.21
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€190.72
12.01.21
12.01.21
-
12.01.22
12.01.22
-10.80%
05.08.21
05.08.21
Aphria Inc.
Start price
Target price
Perf. (%)
€7.48
11.01.21
11.01.21
-
11.01.22
11.01.22
39.14%
15.01.21
15.01.21
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Standard Investments for future growth
High dividend yield expected
Merck KGaA
Start price
Target price
Perf. (%)
€144.55
11.01.21
11.01.21
€145.00
11.01.22
11.01.22
42.10%
12.09.21
12.09.21
Could be very worthwhile Investment >20% year